Clariden Leu (Lux) Generics Equity B
| ISIN: | LU0434325675 | ||||||||||||
| Bloomberg: | CLLGEEB:LX | ||||||||||||
| Termsheet: | Clariden Leu | ||||||||||||
| Management Fee: | 2.00% | ||||||||||||
| Currency: | USD | ||||||||||||
| Performance: |
|
||||||||||||
| Dr. Costa's Rating: | |
||||||||||||
specialised fund on generics pharmaceutical companies with lower volatility and higher relative returns than the Pictet funds. | |||||||||||||

